Molnupiravir
Molnupiravir is a prodrug of the synthetic nucleoside derivative N4-hydroxycytidine. It exerts its antiviral action through introduction of copying errors during viral RNA replication. Activity has been demonstrated against coronaviruses including SARS, MERS and SARS-CoV-2.
